Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 01-2012 | 10-2011 | 07-2011 | 04-2011 | 01-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,482 | 7,119 | 8,839 | 10,457 | 2,941 |
| Receivables | 1,002 | 1,349 | 1,740 | 1,102 | 733 |
| TOTAL | $7,594 | $8,796 | $10,920 | $11,835 | $4,094 |
| Non-Current Assets | |||||
| PPE Net | 452 | 257 | 212 | 146 | 121 |
| Intangibles | 669 | 669 | 669 | 669 | 669 |
| Other Non-Current Assets | 150 | 150 | 0 | 0 | 0 |
| TOTAL | $1,271 | $1,076 | $881 | $815 | $790 |
| Total Assets | $8,865 | $9,872 | $11,801 | $12,650 | $4,884 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,623 | 1,294 | 1,498 | 1,580 | 2,082 |
| Accrued Expenses | 344 | 223 | 264 | 302 | 246 |
| TOTAL | $3,468 | $3,416 | $3,839 | $3,500 | $2,689 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,501 | 1,899 | 2,077 | 1,618 | 361 |
| Other Non-Current Liabilities | 8,777 | 8,843 | 8,954 | 9,131 | 0 |
| TOTAL | $8,777 | $8,843 | $8,954 | $9,131 | $N/A |
| Total Liabilities | $12,245 | $12,259 | $12,793 | $12,631 | $2,689 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,916 | 3,915 | 3,854 | 3,853 | 3,070 |
| Common Shares | 38 | 37 | 37 | 37 | 37 |
| Retained earnings | -22,593 | -20,869 | -18,519 | -16,482 | -13,740 |
| Other shareholders' equity | -319 | -305 | -312 | -320 | -1,060 |
| TOTAL | $-3,380 | $-2,387 | $-992 | $19 | $2,195 |
| Total Liabilities And Equity | $8,865 | $9,872 | $11,801 | $12,650 | $4,884 |